The clinical success of the two BTK inhibitors, ibrutinib and acalabrutinib, represents a major
breakthrough in the treatment of chronic lymphocytic leukemia (CLL) and has also …

The BTK inhibitors ibrutinib and acalabrutinib are FDA-approved drugs for the treatment of B
cell malignances. Both drugs have demonstrated clinical efficacy and safety profiles superior …

Oxidative stress, inflammation, and apoptosis are crucial in the pathogenesis of acute liver
failure (ALF). 4‐Octyl itaconate (OI) showed antioxidative and anti‐inflammatory properties …

Apocynin (APO), a specific nicotinamide adenine dinucleotide phosphate-oxidase (NADPH-
oxidase, NOX) inhibitor, has recently emerged as a bioactive phytochemical with eminent …

Background and aims The monosaccharide mannose has gained recent interest for its
beneficial effect against certain inflammatory disorders. Nevertheless, the influence of …

Inflammation has been convicted of causing and worsening many liver diseases like acute
liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors …

Sepsis is a systemic inflammatory response to a severe, life-threatening infection with organ
dysfunction. Although there is no effective treatment for this fatal illness, a deeper …

Abstract Background and Purpose Pathological retinal angiogenesis is a typical
manifestation of vision‐threatening ocular diseases. Many patients exhibit poor response or …

We herein report a case of idiopathic refractory ascites following allogeneic hematopoietic
cell transplantation that was successfully treated with ibrutinib. A 39-year-old man presented …